ABACAVIR/LAMIVUDINA MYLAN 600mg/300mg tablets - medication leaflet

J05AR02 abacavir + lamivudine

Medicine ABACAVIR/LAMIVUDINA MYLAN 600mg/300mg contains substance abacavir+lamivudine , ATC code J05AR02 - Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations .

General data about ABACAVIR/LAMIVUDINA MYLAN 600mg/300mg MYLAN

Substance: abacavir+lamivudine

Date of last drug list: 01-03-2024

Commercial code: W68224004

Concentration: 600mg/300mg

Pharmaceutical form: tablets

Quantity: 30

Product type: generic

Price: 647.57 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: MYLAN S.A.S. (SAINT PRIEST) - FRANTA

Holder: MYLAN PHARMACEUTICALS LIMITED - IRLANDA

Number: 10824/2018/04

Shelf life: 2 years

Compensation lists for ABACAVIR/LAMIVUDINA MYLAN 600mg/300mg MYLAN

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price

Copayment

Patient

647.57 RON

336.88 RON

310.69 RON